Enzyme-Responsive Polymeric Materials with Anticancer and Antibacterial Activities.
Enzymes are one of the protagonists present in living organisms, which execute numerous biochemical reactions with ultimate chemo/regioselectivity, specificity, and high turnover number under physiolo
APA
Ghosh D, Bag S, De P (2026). Enzyme-Responsive Polymeric Materials with Anticancer and Antibacterial Activities.. Biomacromolecules, 27(1), 16-58. https://doi.org/10.1021/acs.biomac.5c01944
MLA
Ghosh D, et al.. "Enzyme-Responsive Polymeric Materials with Anticancer and Antibacterial Activities.." Biomacromolecules, vol. 27, no. 1, 2026, pp. 16-58.
PMID
41431889
Abstract
Enzymes are one of the protagonists present in living organisms, which execute numerous biochemical reactions with ultimate chemo/regioselectivity, specificity, and high turnover number under physiological conditions. Harnessing these advantages, enzyme-responsive materials endow excellent therapeutic efficiency to ameliorate several healthcare adversities. In parallel, polymeric materials have emerged as powerful therapeutic platforms due to their biocompatibility, tunable architectures, enhanced tissue penetration, and ability to form diverse self-assembled nanostructures. Over recent decades, extensive research has focused on developing enzyme-responsive polymers (ERPs) for various healthcare applications. This review article highlights recent (2014-present) advancements in the field of ERPs for anticancer and antibacterial therapies. Furthermore, several underexplored enzymes are showcased with promising potential for innovative ERP design for impactful future biomedical applications. Overall, this review aims to guide readers in predictably leveraging ERPs to address critical biomedical challenges.
MeSH Terms
Anti-Bacterial Agents; Humans; Antineoplastic Agents; Polymers; Animals; Neoplasms; Enzymes; Nanostructures
같은 제1저자의 인용 많은 논문 (5)
- An overview of commercially available polymers for colon-targeted drug delivery systems.
- Demographic distribution matching between real-world and virtual phantom population.
- Neurotoxicity of chemotherapeutic agents: mechanisms and mitigation strategies.
- Development of novel solid lipid nanoparticles for delivery of astrakurkurone with increasing anti-cancer efficacy against non-small cell lung cancer cells.
- Autophagy is essential for survival and function of polyploid giant cancer cells under therapeutic stress.